Alnylam Pharmaceuticals (ALNY) PT Lowered to $448 at Bernstein SocGen
Tweet Send to a Friend
Bernstein SocGen Group analyst William Pickering lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $448.00 (from $451.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
